Christiana RUHRBERG,Claudio RAIMONDI,Alessandro FANTIN
申请号：
US15113242
公开号：
US20170027936A1
申请日:
2015.01.20
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to an Abelson murine leukaemia viral oncogene homolog 1 (ABL1) inhibitor for use in the treatment of ocular neovascularisation associated with a non-cancerous condition. The invention also relates to the use of an ABL1 inhibitor as a complementary therapy with VEGF or VEGF receptor inhibitor treatment and provides pharmaceutical compos itions and kits comprising one or both inhibitors.
